scholarly journals Can Red Blood Cell Indices Act as Surrogate Markers for Discordance between Hemoglobin A1c and Fasting Blood Glucose?

2016 ◽  
Vol 62 (12) ◽  
pp. 1551-1553
Author(s):  
Robert M Cohen ◽  
Robert S Franco
2016 ◽  
Vol 176 ◽  
pp. 7-9 ◽  
Author(s):  
Robert M. Cohen ◽  
Eric P. Smith ◽  
Shahriar Arbabi ◽  
Charles T. Quinn ◽  
Robert S. Franco

2016 ◽  
Vol 176 ◽  
pp. 197-199 ◽  
Author(s):  
Mahmoud Adeeb Ahmad Hamdan ◽  
James M. Hempe ◽  
Cruz Velasco-Gonzalez ◽  
Ricardo Gomez ◽  
Alfonso Vargas ◽  
...  

2018 ◽  
Vol 104 (3) ◽  
pp. 707-710 ◽  
Author(s):  
Robert M Cohen ◽  
Robert S Franco ◽  
Eric P Smith ◽  
John M Higgins

Commentary placing genetic ancestry markers and racial difference in HbA1c in the context of more common variations in the HbA1c-average glucose relationship and their clinical implications.


2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Renying Xu ◽  
Ting Zhang ◽  
Yanping Wan ◽  
Zhuping Fan ◽  
Xiang Gao

Abstract Background Diabetes has been reported to be associated with carotid artery plaque (CAP). However, it remains unclear whether hemoglobin A1c (HbA1c) level, a marker for long-term glycemic status, is associated with altered CAP risk in individuals with fasting blood glucose (FBG) concentrations below the current cutoff for diabetes. Methods Included were 16,863 Chinese adults (aged 18 years or more; 9855 men and 7008 women) with fasting blood glucose < 7.0 mmol/L at baseline (2013). Both HbA1c level and CAP (assessed via ultrasound B-mode imaging) were annually assessed during 2014–2018. All the participants were further classified into three groups based on baseline HbA1c level: ≤ 5.6%, 5.7–6.4%, and ≥ 6.5%. We used Cox proportional-hazards model to evaluate the association between HbA1c level and incident CAP, adjusting for a series of potential confounders. Results During 5 years of follow up, 3942 incident CAP cases were identified. Individuals with higher baseline HbA1c had higher future risk of CAP (p-trend < 0.001). In the full-adjusted model, each percent increase of HbA1c was associated with a 56% (HR = 1.56, 95% CI 1.37, 1.78) higher risk of CAP. Excluding participants with chronic inflammation, as assessed by high-sensitivity C-reactive protein and white blood cell, and those with FBG ≥ 5.6 mmol/L at baseline generated similar results. Conclusions Elevated HbA1c level was associated with high risk of developing CAP in Chinese adults without FBG defined diabetes.


2015 ◽  
Vol 156 (33) ◽  
pp. 1341-1347
Author(s):  
Emília Mácsai ◽  
Erika Rakk ◽  
Margit Miléder ◽  
Ágnes Fulcz

Introduction: Skin autofluorescence has a well-known significance for screening diabetes and early diagnosis of vascular complications. It predicts cardiovascular events better than hemoglobin A1c, hence skin autofluorescence is a marker of cumulative tissue glycemic load whereas hemoglobin A1c reflects changes occurring in the previous 6–8 weeks. Aim: The aim of the authors was analyze the relationship between skin autofluorescence and conventional glycemic markers in patients with diabetes. Method: Skin autofluorescence measurements were performed in 2010 in 18 patients (10 men and 8 women with normal glomerular filtration rate; age, 61.4±13.8 years) with long term follow-up (2624 months, 476 laboratory results). Relationships between skin autofluorescence values and fasting blood glucose, hemoglobin A1c levels and metabolic parameters obtained before and after skin autofluorescence measurements were analysed using Spearman rank test. Results: The average skin autofluorescence value was 2.88±0.65 arbitrary units. There were no significant correlations between skin autofluorescence and hemoglobin A1c levels obtained before (7.84±1.08%, p = 0.07) and after the skin autofluorescence measurements (7.45±1.18%, p = 0.71). Skin autofluorescence values also failed to show relationship with fasting blood glucose obtained before (p = 0.09) and after (p = 0.29) the skin autofluorescence measurements. Conclusions: In patients with diabetes skin autofluorescence may provide novel information about glycemic burden. Skin autofluorescence values (which may presumably provide a more accurate estimation of the cardiovascular risk) do not correlate with hemoglobin A1c and fasting blood glucose. Orv. Hetil., 2015, 156(33), 1341–1347.


Sign in / Sign up

Export Citation Format

Share Document